Everand Logo

Welcome to Everand!

  • STAT

    ‘It is a bit uncomfortable’: Before the criminal allegations, an awards program honored Insys and Theranos

    “It is a bit uncomfortable to have them on the list,” acknowledged Joan Koerber-Walker, president and CEO of the Arizona BioIndustry Association, whose past honorees include Insys and Theranos.
    by Rebecca Robbins May 08, 2019 3 minutes
    Arizona State Route 202, Red Mountain Freeway, near Phoenix Sky Harbor International Airport.

    When it comes to having a bad corporate reputation, it doesn’t get much worse than Insys Therapeutics and Theranos.

    Last week, five former Insys executives, including founder John Kapoor, were found guilty of racketeering in pushing the company’s powerful opioid; jurors said they were horrified when they saw a music video, produced to pump up sales, featuring two Insys salesmen rapping about ramping up the dose of the painkiller. Meanwhile, ex-Theranos

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
    An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

    Related Books & Audiobooks